ClinicalTrials.Veeva

Menu

An Exploratory Study of Visual Function Rehabilitation in Patients With Ocular Trauma

Sun Yat-sen University logo

Sun Yat-sen University

Status

Not yet enrolling

Conditions

Eye Injuries

Treatments

Device: Perceptual Learning

Study type

Interventional

Funder types

Other

Identifiers

NCT06174415
2023KYPJ122

Details and patient eligibility

About

Ocular trauma is one of the leading causes of blindness worldwide, often resulting in severe visual impairment or even loss of vision after injury.

Although after powerful surgical treatment, there are still some patients whose visual function is difficult to improve, and the patients with eye trauma lack effective vision rehabilitation therapy.Therefore, the research on visual function rehabilitation of patients with ocular trauma needs to be further carried out . Perceptual learning is based on cortical remodeling, repetitive visual task training. This training is to perform a series of repetitive visual tasks through the Gabor patch, simulating the receptive field structure of simple cells in the primary visual cortex (V1 area), "awakening visual cells", and improving the visual processing ability of the cerebral cortex. Compared with the traditional vision rehabilitation therapy, perceptual learning optimizes the visual quality at the visual center level. It is an innovative therapy, having the potential to solve the visual function of patients with eye trauma. This study intends to explore new visual rehabilitation methods for patients with ocular trauma, and explore the changes in visual cortical function and area of patients after perceptual training.

Full description

Perceptual training is a type of perceptual learning that initiates neural modifications during continuous repetitive task training, thereby increasing neural efficiency and improving the visual processing capabilities of the cerebral cortex. The perceptual training program simulates the receptive field structure of simple cells in the primary visual cortex (area V1) through Gabor cursors and lateral occlusion techniques to awaken visual cells during repetitive visual tasks. Gabor Patches are targeted stimuli that are widely used in the field of optic neurology to produce highly effective stimulation of the primary visual cortex. Lateral shading technology can effectively stimulate specific neurons. It can not only improve the interaction of neurons in the cerebral cortex in patients with amblyopia, but also stimulate the cooperation of neurons. This technology has also been proved to be effective in normal people. Therefore, on the basis of this theory, we plan to use perceptual learning to conduct repetitive visual stimulation for three months, and return to visit three times within three months. The main indicator is contrast sensitivity, and the efficacy of perceptual learning is evaluated by evaluating the improvement of contrast sensitivity. The study was designed as a self-controlled before-and-after trial. Volunteers were recruited from the outpatients of Zhongshan Ophthalmic Center's ophthalmic trauma clinic to participate in the study.

Enrollment

20 estimated patients

Sex

All

Ages

3 to 60 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Retinopathy, optic neuropathy, endophthalmitis and other injuries caused by ocular trauma, with varying degrees of central vision reduction and visual field impairment
  2. Age 3~60 years old
  3. Best corrected visual acuity of the affected eye: 20/200≤BCVA≤20/25
  4. Intraocular pressure is normal, non-hypotonal/atrophic: 7--21mmHg
  5. After the traumatic injury, the condition is stable ≥for 3 months after treatment, and the visual axis has a complete and transparent optical pathway
  6. If the patient is injured in one eye, There were no abnormal lesions in the contralateral eye, no abnormalities in slit lamp and indirect ophthalmoscopy, and no peripheral retinopathy in both eyes was found on triprimmoscopy. Carefully ask for a history of no other eye disease in both eyes and a systemic history that has caused an associated eye disease or has affected visual formation.
  7. The cranial structure is intact, the function is good, and there is no primary or secondary injury
  8. Able to cooperate with the questionnaire and treatment, good compliance
  9. Those who are willing to sign the informed consent form

Exclusion criteria

  1. Have active inflammation of the eye
  2. Previous abnormal intraocular blood supply such as occlusion of the central intraocular artery due to trauma or non-traumatic factors
  3. History of other non-traumatic intraocular surgery
  4. Ocular related lesions caused by other non-traumatic factors that can interfere with this study, such as age-related macular degeneration, glaucoma, amblyopia, etc.
  5. Use of other rehabilitation training methods or visual aids 3 months before enrollment
  6. Lesions with systemic diseases whose degree of lesions have affected visual function, such as diabetic retinopathy, Hypertension and arteriosclerotic fundus changes, rubella-related ocular changes, etc.
  7. Patients with severe systemic diseases such as renal failure and malignant hypertension or may affect visual function (such as retinal structure and function, choroidal structure and function, etc.)
  8. Patients with congenital ocular lesions
  9. Patients with optic nerve and retinopathy caused by non-traumatic factors
  10. Patients with cranial brain disease or craniocere-related lesions with poor cortical function
  11. Psychological related diseases
  12. MRI contraindications, Such as claustrophobia and non-MRI compatible metal implants
  13. people with speech impairment and intellectual disability
  14. those who are considered inappropriate by the investigator

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

20 participants in 1 patient group

Experimental group
Experimental group
Description:
The experimental group consisted of the patients themselves. Compare data before and after treatment
Treatment:
Device: Perceptual Learning

Trial contacts and locations

1

Loading...

Central trial contact

WANQI QIAN

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems